Tongalp H. Tezel, M.D.
"Patients should receive the utmost care, which includes an up-to-date clinical knowledge, accurate and individualized clinical decision making and perfect surgical skills. I believe the combination of these with honesty and respect is a guarantee for professional success and satisfaction."
To Schedule an Appointment with Dr. Tezel, Call (502) 897-9881 or (502) 852-5466
Dr. Tezel's main clinical interest is focused on the surgical and medical treatment of vitreoretinal diseases. Vitreous is the gel that fills the center of the eye and attaches firmly to the retina which is the light-sensitive inner lining of the eye. Retina converts the light into nerve signals and sends them along the optic nerve to the brain where these signals are decoded to form visual perception. Diseases affecting the retina and vitreous manifest themselves with significant visual problems since disorders of the retina do not allow the eye to communicate with the brain. Some examples of such diseases include age-related macular degeneration, diabetic retinopathy, macular holes, epiretinal membranes, retinal detachment, vein occlusions and ocular tumors. For the treatment of these disorders, Dr. Tezel use injection of drugs into the eye, lasers or surgical means. He follows the treatment guidelines obtained from several clinical trials and discuss with his patients the outcome expectations prior to application of these treatments.
Dr. Tezel is a leader in his field and has been listed as “Top Doctor” by Who’s Who Index and Best Doctor’s in America List. His clinical practice involves the most updated medical and surgical care for these diseases combined with an treatment plans individualized for his patients’ needs.
Dr. Tezel has also been intensely involved in cutting-edge retinal research including investigating new treatment for age-related macular degeneration such as development of new drugs and retinal cell transplantation techniques. He has an active laboratory which is focused on investigating the molecular mechanisms of various retinal diseases using advanced experimental techniques, such as proteomic analysis. His innovative works resulted in several new patents regarding the discovery of new treatment options for patient with retinal diseases.
Current Position
Associate Professor, Kentucky Lions Endowed ChairDepartment of Ophthalmology and Visual Sciences,
Department of Anatomical Sciences and Neurobiology;
Director of, Fellowship Program in Vitreoretinal Diseases and Surgery
Specialties
Surgical and Medical Treatment of Vitreoretinal Diseases
Board Certification
American Board of Ophthalmology- 2003
Medical License
Kentucky
Indiana
New York
Contact Information
University of Louisville School of Medicine
Department of Ophthalmology and Visual Sciences
Kentucky Lions Eye Institute
301 East Muhammad Ali Boulevard
Louisville, KY 40202
Phones:
Office-
(502) 852-4881
(502) 897-9881
Fax-
(502) 852-3811
Labs-
(502) 852-3826
(502) 852-2737
(502) 852-7316
Tongalp.Tezel@louisville.edu
Research Website
Laboratory of Tongalp H. Tezel, MD
Education
Hacettepe University Medical School, 1978-1984
Hacettepe University Hospitals, Ankara, Turkey, Internship, 1983-84
Department of Ophthalmology, Ankara Numune Hospital, Ankara, Turkey, Residency, 1986-1989
Department of Ophthalmology, Rigshospitalet Copenhagen University School of Medicine, Copenhagen, Denmark, Clinical Fellowship in Vitreoretinal Surgery, 1993-1994
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, Fellowship in Vitreoretinal Research, 1994-1997
Department of Internal Medicine, St. Mary's Health Center, St. Louis, Missouri, Internship, 1998-1999
Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri, Residency in Ophthalmology, 1999-1902
College of Physicians and Surgeons of Columbia University, Department of Ophthalmology, New York, NY, Clinical Fellowship in Vitreoretinal Surgery, 2002-2003
Professional Societies and Affiliations
American Academy of Ophthalmology - Diplomate
Association for Research in Vision and Ophthalmology
American Society of Retina Specialists
The Macula Society
The Retina Society
Kentucky Association of Eye Physicians and Surgeons
Louisville Academy of Ophthalmology
Jefferson County Medical Society
Research to Prevent Blindness
Washington University Alumni Association
Columbia College of Physicians and Surgeons Association
Select Publications
Tezel TH, Del Priore LV, Kaplan HJ. Re-engineering of aged Bruch's membrane to enhance retinal pigment epithelium repopulation. A new model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2004; 45:3337-3348.
Tezel TH, Bora N, Kaplan, HJ. Pathogenesis of Age-related Macular Degeneration. Trends in Mol Med, 2004; 10(9):417-420.
Tezel TH, Del Priore LV: Reattachment to a substrate prevents apoptosis of human retinal pigment epithelium. Graefe's Arch Clin Exp Ophthalmol 1997;235:41-47.
Tezel TH, Kaplan HJ, Del Priore LV. Posterior vitreous detachment with Dispase. Retina 1998;18:7-15.
Tezel TH, Del Priore LV, Kaplan HJ. Fate of human retinal pigment epithelial cells seeded onto layers of Bruch's membrane. Invest Ophthalmol Vis Sci 1999;40:467-76.
Tezel TH, Kaplan HJ. Are Are intravitreal anti-VEGF antibodies safe.pdfintravitreal anti-VEGF antibodies safe? Ocul
Immunol Inflamm, 2007; 15:1-2
Tezel TH. Intraocular pharmacotheraphy: specificity and safety issues.
Expert Rev Ophthalmol, 2007;2:671-675.
Tezel TH, Del Priore LV, Berger A, Kaplan HJ. Adult retinal pigment
epithelium transplantation in exudative age-related macular degeneration. Am
J Ophthalmol, 2007; 143: 584-595.
Tezel TH, Kaplan HJ. Are intravitreal anti-VEGF antibodies safe? Ocul Immunol Inflamm, 2007; 15:1-2
Tezel TH. Intraocular pharmacotheraphy: specificity and safety issues. Expert Rev Ophthalmol, 2007;2:671-675.
Tezel TH, Del Priore LV, Berger A, Kaplan HJ. Adult retinal pigment epithelium transplantation in exudative age-related macular degeneration. Am J Ophthalmol, 2007; 143: 584-595.
